European Medicines Agency recommends that Linoladiol N and Linoladiol HN remain available
Benefits continue to outweigh risks with new restrictions
06-Jan-2014 -
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has concluded that Linoladiol N and Linoladiol HN, two high-strength estradiol-containing creams used for topical treatment of diseases of the genital area in women who have been through the menopause, may ...
atrophy
cancer
cervical cancer
+7